Mazor Robotics Promotes Internally for CEO of U.S. Subsidiary

Mazor Robotics Ltd., a developer of guidance systems used in spinal surgery, has promoted Christopher Prentice, senior vice president America and global marketing, to CEO of Mazor Robotics Inc., the U.S. subsidiary of the company.

Prentice will report directly to Ori Hadomi, CEO of Caesarea, Israel-based Mazor Robotics Ltd.

“Chris’ contribution to our growth, from strategic planning to tactical execution, has been critical to our success,” said Hadomi. “The U.S. market represents our greatest growth opportunity and I am confident that Chris’ leadership, talent and proven capabilities will allow us to realize our objectives.”

“Mazor Robotics’ clinical and economic value to patients, surgical teams, and hospitals has driven our growth, orchestrated by a wonderful team of professionals,” said Prentice. “I feel privileged and honored to take on these new responsibilities, and I look forward to leading the team to ensure Mazor’s continued success and growth in the U.S. market.”

Prentice has spent the past 16 years in healthcare management roles with a focus on advancing new technologies in surgical fields. Prior to joining Mazor in 2010, he held leadership positions in marketing and sales at Ethicon Endo-Surgery, a Johnson & Johnson company; Intuitive Surgical Inc.; and in finance at Tampa General Hospital. Prentice graduated from the United States Military Academy at West Point, has an MBA from Western New England University, and an master’s degree in healthcare administration from the University of South Florida.

Mazor Robotics’ flagship product, Renaissance, is a surgical guidance system that enables surgeons to conduct spine surgeries. Mazor Robotics systems successfully have been used in the placement of more than 50,000 implants worldwide, according to the company.